Literature DB >> 18763001

Idarubicin inhibits the growth of bacteria and yeasts in an automated blood culture system.

U Kinnunen1, H Syrjälä, P Koistinen, M Koskela.   

Abstract

The effect of anti-neoplastic agents on the growth of microorganisms was studied in vitro using aerobic BacT/Alert standard and FAN bottles as the culture media. A 50% longer incubation period to detect microbial growth compared to the control group was interpreted as growth inhibition. Idarubicin inhibited the growth of all of the five gram-positive cocci, one of five gram-negative rods and one of three yeast strains studied in the standard bottles but not in the FAN bottles. Candida glabrata was the most sensitive strain. Its growth was inhibited in the presence of idarubicin at a concentration of 1 micromol/l.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763001     DOI: 10.1007/s10096-008-0613-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  Effects of anti-neoplastic agents on the recovery of bacteria and yeasts in an automated blood culture system.

Authors:  U Kinnunen; P Koistinen; H Syrjälä; M Koskela
Journal:  Scand J Infect Dis       Date:  2000

2.  Plasma pharmacokinetics of Idarubicin and its 13-hydroxymetabolite after intravenous and oral administration under fasting and non-fasting conditions.

Authors:  S Eksborg; M Söderberg; B Nilsson; K Antila
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

3.  Clinical pharmacology of oral thioguanine in acute myelogenous leukemia.

Authors:  L W Brox; L Birkett; A Belch
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia.

Authors:  T A Madani
Journal:  Infection       Date:  2000 Nov-Dec       Impact factor: 3.553

5.  Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.

Authors:  C Harter; B Schulze; H Goldschmidt; A Benner; H K Geiss; T Hoppe-Tichy; A D Ho; G Egerer
Journal:  Bone Marrow Transplant       Date:  2006-02       Impact factor: 5.483

6.  A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia.

Authors:  R A Larson; K M Daly; K E Choi; D S Han; J A Sinkule
Journal:  J Clin Oncol       Date:  1987-03       Impact factor: 44.544

7.  Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.

Authors: 
Journal:  J Clin Oncol       Date:  1983-10       Impact factor: 44.544

8.  Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

Authors:  P Y Bochud; P Eggiman; T Calandra; G Van Melle; L Saghafi; P Francioli
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

9.  Antimicrobial activity of cytotoxic drugs may influence isolation of bacteria and fungi from blood cultures.

Authors:  V Peiris; B A Oppenheim
Journal:  J Clin Pathol       Date:  1993-12       Impact factor: 3.411

10.  Influence of chemotherapy courses on the rate of bloodstream infections during neutropenia in adult acute myeloid leukaemia.

Authors:  Urpo Kinnunen; Pirjo Koistinen; Pasi Ohtonen; Markku Koskela; Hannu Syrjälä
Journal:  Scand J Infect Dis       Date:  2008
  10 in total
  2 in total

Review 1.  Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.

Authors:  Sharon C-A Chen; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

2.  Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus.

Authors:  Pengfei She; Shijia Li; Linying Zhou; Zhen Luo; Jinfeng Liao; Lanlan Xu; Xianghai Zeng; Ti Chen; Yaqian Liu; Yong Wu
Journal:  Virulence       Date:  2020-01-01       Impact factor: 5.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.